The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings. [electronic resource]
- The Journal of infectious diseases Jun 2013
- S45-8 p. digital
Publication Type: Congress; Research Support, Non-U.S. Gov't
1537-6613
10.1093/infdis/jit121 doi
Anti-Retroviral Agents--pharmacology Developing Countries Drug Resistance, Viral Drug Therapy, Combination HIV--drug effects HIV Infections--drug therapy Humans World Health Organization